“A Double Blind, Randomized, Placebo Controlled Clinical Study To Evaluate The Efficacy And Safety Of Tfn34 Tablets For Individuals With Subclinical And Clinical Hypothyroidism” (2022) Journal of Pharmaceutical Negative Results, pp. 8599–8614. doi:10.47750/pnr.2022.13.S09.1010.